RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways

[1]  M. Furue,et al.  The pruritogenic mediator endothelin‐1 shifts the dendritic cell–T‐cell response toward Th17/Th1 polarization , 2018, Allergy.

[2]  F. Ciccarelli,et al.  An analysis of IL-36 signature genes and individuals with IL1RL2 knockout mutations validates IL-36 as a psoriasis therapeutic target , 2017, Science Translational Medicine.

[3]  C. Xiao,et al.  CD100-Plexin-B2 Promotes the Inflammation in Psoriasis by Activating NF-κB and the Inflammasome in Keratinocytes. , 2017, The Journal of investigative dermatology.

[4]  A. Wollenberg,et al.  Unopposed IL-36 Activity Promotes Clonal CD4+ T-Cell Responses with IL-17A Production in Generalized Pustular Psoriasis. , 2017, The Journal of investigative dermatology.

[5]  Jan Kremláček,et al.  Roles of miR-31 and endothelin-1 in psoriasis vulgaris: pathophysiological functions and potential biomarkers. , 2017, Physiological research.

[6]  A. Amato,et al.  Nutrient consumption and chain tuning in diatoms exposed to storm-like turbulence , 2017, Scientific Reports.

[7]  Xiaoxia Zhu,et al.  New Interleukins in Psoriasis and Psoriatic Arthritis Patients: The Possible Roles of Interleukin-33 to Interleukin-38 in Disease Activities and Bone Erosions , 2017, Dermatology.

[8]  S. Arron,et al.  Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin , 2017, Scientific Reports.

[9]  P. Sætrom,et al.  Pathway Analysis of Skin from Psoriasis Patients after Adalimumab Treatment Reveals New Early Events in the Anti-Inflammatory Mechanism of Anti-TNF-α , 2016, PloS one.

[10]  M. Suárez-Fariñas,et al.  Based on Molecular Profiling of Gene Expression, Palmoplantar Pustulosis and Palmoplantar Pustular Psoriasis Are Highly Related Diseases that Appear to Be Distinct from Psoriasis Vulgaris , 2016, PloS one.

[11]  M. Suárez-Fariñas,et al.  Molecular and Cellular Profiling of Scalp Psoriasis Reveals Differences and Similarities Compared to Skin Psoriasis , 2016, PloS one.

[12]  Gang Wang,et al.  Impaired function of regulatory T cells in patients with psoriasis is mediated by phosphorylation of STAT3. , 2016, Journal of dermatological science.

[13]  S. Pittaluga,et al.  Hair follicle-derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma , 2015, Nature Medicine.

[14]  Zhaoyuan Liu,et al.  Epigenetic Downregulation of SFRP4 Contributes to Epidermal Hyperplasia in Psoriasis , 2015, The Journal of Immunology.

[15]  Kristi Abram,et al.  Transcriptional landscape of psoriasis identifies the involvement of IL36 and IL36RN , 2015, BMC Genomics.

[16]  Michael Hölzel,et al.  IL-36γ (IL-1F9) is a biomarker for psoriasis skin lesions. , 2015, The Journal of investigative dermatology.

[17]  A. Troxel,et al.  Palmoplantar psoriasis is associated with greater impairment of health-related quality of life compared with moderate to severe plaque psoriasis. , 2014, Journal of the American Academy of Dermatology.

[18]  Andrew Johnston,et al.  Transcriptome analysis of psoriasis in a large case-control sample: RNA-seq provides insights into disease mechanisms , 2014, The Journal of investigative dermatology.

[19]  P. Di Meglio,et al.  CD8 T Cells and IFN-γ emerge as critical players for psoriasis in a novel model of mouse psoriasiform skin inflammation. , 2013, The Journal of investigative dermatology.

[20]  R. Clark,et al.  CD8(+) T cells in the lesional skin of atopic dermatitis and psoriasis patients are an important source of IFN-γ, IL-13, IL-17, and IL-22. , 2013, The Journal of investigative dermatology.

[21]  Mayte Suárez-Fariñas,et al.  Expanding the Psoriasis Disease Profile: Interrogation of the Skin and Serum of Patients with Moderate-to-Severe Psoriasis , 2012, The Journal of investigative dermatology.

[22]  Andrew E. Jaffe,et al.  Bioinformatics Applications Note Gene Expression the Sva Package for Removing Batch Effects and Other Unwanted Variation in High-throughput Experiments , 2022 .

[23]  David R. Kelley,et al.  Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks , 2012, Nature Protocols.

[24]  L. Beck,et al.  Aldo-keto Reductase 1C3 (AKR1C3) is Expressed in Differentiated Human Epidermis, Affects Keratinocyte Differentiation and is Upregulated in Atopic Dermatitis , 2011, The Journal of investigative dermatology.

[25]  G. Vena,et al.  Alcohol, psoriasis, liver disease, and anti‐psoriasis drugs , 2011, International journal of dermatology.

[26]  P. van Erp,et al.  Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin. , 2011, The Journal of investigative dermatology.

[27]  D. Gladman,et al.  IL13 gene polymorphism is a marker for psoriatic arthritis among psoriasis patients , 2011, Annals of the rheumatic diseases.

[28]  Elizabeth A. Grice,et al.  The skin microbiome , 2020, Nature.

[29]  Juan Cheng,et al.  Increased Th17 cells are accompanied by FoxP3(+) Treg cell accumulation and correlated with psoriasis disease severity. , 2010, Clinical immunology.

[30]  J. Krueger,et al.  New insights in the immunologic basis of psoriasis. , 2010, Seminars in cutaneous medicine and surgery.

[31]  A. Levine,et al.  IL-6 Signaling in Psoriasis Prevents Immune Suppression by Regulatory T Cells1 , 2009, The Journal of Immunology.

[32]  Pilar Romero,et al.  IL‐17‐producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17‐related cytokines , 2009, Journal of leukocyte biology.

[33]  C. Guinot,et al.  Psoriasis: characterization of six different clinical phenotypes , 2009, Experimental dermatology.

[34]  E. Adışen,et al.  A retrospective analysis of treatment responses of palmoplantar psoriasis in 114 patients , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[35]  M. Lebwohl,et al.  Treatment of severe scalp psoriasis: from the Medical Board of the National Psoriasis Foundation. , 2009, Journal of the American Academy of Dermatology.

[36]  Martin L. Moore,et al.  A Functional IL-13 Receptor Is Expressed on Polarized Murine CD4+ Th17 Cells and IL-13 Signaling Attenuates Th17 Cytokine Production1 , 2009, The Journal of Immunology.

[37]  Steve Horvath,et al.  WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.

[38]  W. Alkema,et al.  BioVenn – a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams , 2008, BMC Genomics.

[39]  C. Albanesi,et al.  IL-4 and IL-13 Negatively Regulate TNF-α- and IFN-γ-Induced β-Defensin Expression through STAT-6, Suppressor of Cytokine Signaling (SOCS)-1, and SOCS-31 , 2007, The Journal of Immunology.

[40]  L. Harrington,et al.  Expanding the effector CD4 T-cell repertoire: the Th17 lineage. , 2006, Current opinion in immunology.

[41]  S. Stevens,et al.  Dysfunctional Blood and Target Tissue CD4+CD25high Regulatory T Cells in Psoriasis: Mechanism Underlying Unrestrained Pathogenic Effector T Cell Proliferation1 , 2005, The Journal of Immunology.

[42]  J. Travers,et al.  Cytokine Milieu of Atopic Dermatitis, as Compared to Psoriasis, Skin Prevents Induction of Innate Immune Response Genes 1 , 2003, The Journal of Immunology.

[43]  S. Feldman,et al.  Patients with palmoplantar psoriasis have more physical disability and discomfort than patients with other forms of psoriasis: implications for clinical practice. , 2003, Journal of the American Academy of Dermatology.

[44]  D. Tobin,et al.  The human hair follicle immune system: cellular composition and immune privilege , 2000, The British journal of dermatology.

[45]  G. Seghieri,et al.  Increased levels of plasma endothelin-1 in patients with psoriasis. , 1994, Clinica chimica acta; international journal of clinical chemistry.

[46]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[47]  C. Albanesi,et al.  IL-4 and IL-13 Negatively Regulate TNF--and IFN- -Induced -Defensin Expression through STAT-6, Suppressor of Cytokine Signaling (SOCS)-1, and SOCS-3 , 2007 .